Mr. Tetsuo Inoue and Mr. B-Comi's Hybrid Battle 'Verification Stock' saw growth rates exceeding 30% in March, April, and May.

From Mr. Tetsuo Inoue's corporate ranking report, Mr. B-Comi boldly selects and introduces "attention-worthy stocks." The June filming of Winner's Screening-Stock Hybrid Battle- has just finished.Winner's Screening-Stock Hybrid Battle- has just finished.

From today's recording, we'd like to excerpt and present a portion.

Each time, the seminar introduction begins with Mr. Inoue's supply-demand and technical analysis, but this time the combined RSI of the Nikkei Average and the Dow Average precisely signaled both the March bottom and the current peak, reaffirming the high precision of RSI-total as a technical indicator, according to both gentlemen.

They also discuss an analysis of the trajectory of Japanese stocks since September 2019, including the decline during the COVID-19 pandemic and the subsequent rally.

We can't take our eyes off whether TOPIX and Mothers stocks will continue to rise in the future.

In the program's latter half, in the segment analyzing individual stocks, the discussion turned to the performance of the "Test Stocks" announced in every episode since the Hybrid Battle began in December 2018.

Overall, it rose 13.1%, a quite impressive performance, but in March, April, and May 2020 there were periods with gains exceeding 30%, recording results worthy of high praise.

From this set of "Test Stocks," we would like to introduce one stock.

　That stock is 2930 Kita no Tatsujin Corporation.

According to Mr. B-Comi, the performance of health-food stocks is driven by hit products.

has a hyaluronic acid tape-type product that helps reduce wrinkles around the eyes and is becoming a hit product.

The tape's thorn-like projections make it less likely to come off, and when applied to the face, it allows hyaluronic acid to be absorbed efficiently into the skin, a point that is valued especially by middle-aged and older people.

Inoue Tetsuo's analytical data is also provided.

If you watch the main program, you'll see that even more stocks are analyzed.

Written by Hayakawa